Skip to main content
. 2021 Jul 18;13(1):188–200. doi: 10.1007/s13340-021-00522-5

Table 7.

Odds ratio (95% CI) for the quartiles of novel anthropometric indices to identify MetS and its components after adjustment for age, sex, BMI, history of smoking, and alcohol intake

Variables MetS Central Obesity Hyperglycemia High TG Low HDL-C Raised BP
ABSI
Q1 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Q2 (0.0792) 1.36 (0.61–3.04) 2.92* (1.22–6.98) 1.36 (0.62–2.98) 0.61 (0.24–1.54) 0.96 (0.42–2.22) 0.71 (0.29–1.70)
Q3 (0.0832) 2.04 (0.92–4.53) 3.72* (1.56–8.86) 1.47 (0.67–3.23) 1.16 (0.49–2.70) 1.15 (0.512.62) 0.79 (0.33–1.87)
Q4 (0.0877) 8.60* (3.42–21.59) 14.90* (5.70–38.9) 4.23* (1.83–9.47) 2.27* (1.00–5.15) 2.23 (1.00–4.97) 1.15 (0.50–2.65)
AVI
Q1 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Q2 (16.21) 5.47* (2.20–13.60) 4.55* (2.01–10.44) 3.02* (1.34–6.82) 1.47 (0.55–3.88) 2.77* (1.14–6.73) 1.16 (0.48–2.82)
Q3 (18.26) 6.88* (2.77–17.08) 6.02* (2.32–15.17) 4.26* (1.85–9.82) 2.47 (0.98–6.19) 3.34* (1.37–8.14) 1.25 (0.52–3.00)
Q4 (20.41) 18.20* (6.69–49.4) 24.77* (7.70–57.61) 5.95* (2.42–14.15) 5.27* (2.11–13.14) 3.78* (1.56–9.18) 1.29 (0.54–3.07)
BAI
Q1 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Q2 (26.77) 1.21 (0.55–2.69) 3.64* (1.50–8.81) 1.03 (0.47–2.26) 0.93 (0.39–2.21) 0.86 (0.38–1.96) 0.90 (0.37–2.18)
Q3 (30.03) 1.49 (0.67–3.27) 4.44* (1.83–10.77) 1.08 (0.49–2.35) 1.09 (0.47–2.55) 1.00 (0.44–2.23) 1.13 (0.47–2.68)
Q4 (35.27) 5.49* (2.29 – 13.16) 12.98* (5.03 – 33.51) 2.89* (1.26 – 6.61) 1.60 (0.70 – 3.65) 1.32 (0.59 – 2.93) 1.24 (0.52 – 2.92)
BRI
Q1 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Q2 (4.29) 11.57* (3.64–36.7) 3.23* (1.07–9.72) 4.41* (1.85–10.46) 1.66 (0.62–4.47) 4.40* (1.58–12.28) 2.22 (0.80–6.11)
Q3 (5.07) 16.66* (5.17–53.6) 14.14* (4.77–41.96) 4.67* (1.94–11.22) 1.87 (0.71–4.92) 6.30* (2.27–17.51) 2.61 (0.96–7.08)
Q4 (6.09) 66.03* (18.01–242.1) 86.60* (24.30–323.8) 9.31* (3.69–23.48) 6.73* (2.61–17.33) 6.83* (2.49–18.74) 3.63* (13.7–9.6)
CI
Q1 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Q2 (0.98) 1.73 (0.76–3.94) 8.62* (2.33–15.85) 1.56 (0.71–3.45) 0.69 (0.26–0.79) 1.22 (0.52–2.83) 1.23 (0.50–3.02)
Q3 (1.05) 2.81* (1.24–6.35) 21.20* (6.20–47.68) 1.99 (0.90–4.38) 1.35 (0.56–3.22) 1.73 (0.76–3.94) 1.50 (0.62–3.62)
Q4 (1.13) 39.01* (10.50–144.7) 58.30* (17.48–180.1) 8.07* (3.06–18.66) 4.41* (1.89–10.30) 3.07* (1.35–6.99) 2.10 (0.88–5.00)
LAP
Q1 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Q2 (30.74) 1.00 (0.46–2.20) 1.25 (0.46–3.34) 1.32 (0.60–2.91) 0.79 (0.22–2.80) 1.15 (0.50–2.64) 2.40 (0.91–6.26)
Q3 (41.46) 1.04 (0.47–2.29) 7.91* (3.16–19.77) 1.74 (0.79–3.81) 2.44 (0.84 7.04) 1.22 (0.53–2.77) 2.55 (0.98–6.61)
Q4 (58.13) 4.39* (1.83–10.52) 11.25* (4.66–27.91) 3.13* (1.36–7.15) 37.58* (12.01–107.6) 7.04* (2.37–18.88) 2.78* (1.07–7.26)
VAI
Q1 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Q2 (3.21) 0.54 (0.24–1.24) 1.56 (0.68–3.62) 0.71 (0.31–1.60) 0.37 (0.06–2.03) 0.62 (0.24–1.63) 2.17 (0.83–5.71)
Q3 (3.91) 1.66 (0.76–3.62) 4.40* (1.88–10.28) 2.18* (1.12–5.48) 4.87* (1.64–14.42) 1.68 (0.72–3.92) 2.68*(1.03–6.97)
Q4 (5.51) 6.59* (2.57–16.87) 5.44* (2.33–12.66) 5.42* (2.22–13.25) 38.77* (13.81–108.3) 8.76* (3.53–21.73) 3.22* (1.24–8.37)
WTI
Q1 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref) 1 (Ref)
Q2 (118.27) 3.85* (1.64–9.03) 1.17 (0.50–2.76) 2.62* (1.15–5.94) 1.09 (0.50–2.36) 1.88 (0.79–4.45) 1.40 (0.53–3.69)
Q3 (144.43) 4.17* (1.77–9.79) 3.39* (1.47–7.77) 3.61* (1.58–8.25) 6.11* (2.60–15.42) 2.40* (1.02–5.64) 2.48 (0.98–6.24)
Q4 (170.71) 9.01* (3.64–22.29) 9.11* (3.66–22.65) 6.00* (2.52–14.24) 46.0* (13.92–141.96) 8.92* (3.69–22.86) 2.79* (1.11–7.02)

Q1, Q2, Q3, Q4 quartiles, Ref reference group. Abbreviations as in Tables 2 and 3

*p < 0.05